And the last two paragraphs of a Motley Fool summary of today's SPL announcement reads:
"But while this is undoubtedly promising news for all involved and could mean Starpharma has a bright future ahead of it, it is worth remembering that there is still a long road ahead before the company comes close to generating revenue from DEP docetaxel.
In light of this, I would suggest investors keep Starpharma on their watchlist and consider an investment in industry behemoth CSL Limited (ASX: CSL) for now instead."
Bahahahaaa. MF continue to have no idea. Yes subscribers, wait until the company has ZERO risk left before a little purchase of SPL shares at multiples of today's closing price. Fools.
Ann: DEP docetaxel positive phase 1 results, phase 2 commences, page-50
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |